Page last updated: 2024-10-25

ciglitazone and Empyema, Gall Bladder

ciglitazone has been researched along with Empyema, Gall Bladder in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research Excerpts

ExcerptRelevanceReference
" Ciglitazone inhibits the inflammation of HGBECs in vitro and has potential therapeutic effect on cholecystitis in vivo."3.73Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells. ( Cheng, NS; Li, SF; Liu, JW; Pan, GD; Wu, H; Xiong, XZ; Yan, LN; Zhang, GF, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, GD1
Wu, H1
Liu, JW1
Cheng, NS1
Xiong, XZ1
Li, SF1
Zhang, GF1
Yan, LN1

Other Studies

1 other study available for ciglitazone and Empyema, Gall Bladder

ArticleYear
Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.
    World journal of gastroenterology, 2005, Oct-14, Volume: 11, Issue:38

    Topics: Cells, Cultured; Cholecystitis; Epidermal Growth Factor; Epithelial Cells; Gallbladder; Humans; Infl

2005